rs2067011

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BA1

The NM_000843.4(GRM6):​c.1353T>C​(p.Asn451Asn) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.544 in 1,609,530 control chromosomes in the GnomAD database, including 239,795 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 19954 hom., cov: 32)
Exomes 𝑓: 0.55 ( 219841 hom. )

Consequence

GRM6
NM_000843.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0001885
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: -1.06

Publications

28 publications found
Variant links:
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
ZNF454 (HGNC:21200): (zinc finger protein 454) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.227).
BP6
Variant 5-178988936-A-G is Benign according to our data. Variant chr5-178988936-A-G is described in ClinVar as Benign. ClinVar VariationId is 99627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.06 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.553 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRM6NM_000843.4 linkc.1353T>C p.Asn451Asn splice_region_variant, synonymous_variant Exon 7 of 11 ENST00000517717.3 NP_000834.2 O15303
ZNF454XR_007058600.1 linkn.5644-811A>G intron_variant Intron 5 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRM6ENST00000517717.3 linkc.1353T>C p.Asn451Asn splice_region_variant, synonymous_variant Exon 7 of 11 5 NM_000843.4 ENSP00000430767.1 O15303

Frequencies

GnomAD3 genomes
AF:
0.507
AC:
76999
AN:
151864
Hom.:
19925
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.412
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.530
Gnomad ASJ
AF:
0.484
Gnomad EAS
AF:
0.571
Gnomad SAS
AF:
0.480
Gnomad FIN
AF:
0.567
Gnomad MID
AF:
0.465
Gnomad NFE
AF:
0.553
Gnomad OTH
AF:
0.478
GnomAD2 exomes
AF:
0.532
AC:
130866
AN:
246060
AF XY:
0.526
show subpopulations
Gnomad AFR exome
AF:
0.406
Gnomad AMR exome
AF:
0.572
Gnomad ASJ exome
AF:
0.483
Gnomad EAS exome
AF:
0.584
Gnomad FIN exome
AF:
0.566
Gnomad NFE exome
AF:
0.546
Gnomad OTH exome
AF:
0.528
GnomAD4 exome
AF:
0.547
AC:
797723
AN:
1457548
Hom.:
219841
Cov.:
35
AF XY:
0.543
AC XY:
393665
AN XY:
725056
show subpopulations
African (AFR)
AF:
0.405
AC:
13541
AN:
33400
American (AMR)
AF:
0.569
AC:
25351
AN:
44524
Ashkenazi Jewish (ASJ)
AF:
0.482
AC:
12564
AN:
26082
East Asian (EAS)
AF:
0.553
AC:
21935
AN:
39650
South Asian (SAS)
AF:
0.462
AC:
39680
AN:
85970
European-Finnish (FIN)
AF:
0.569
AC:
30320
AN:
53240
Middle Eastern (MID)
AF:
0.421
AC:
2080
AN:
4944
European-Non Finnish (NFE)
AF:
0.559
AC:
620043
AN:
1109546
Other (OTH)
AF:
0.535
AC:
32209
AN:
60192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
17271
34541
51812
69082
86353
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17404
34808
52212
69616
87020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.507
AC:
77071
AN:
151982
Hom.:
19954
Cov.:
32
AF XY:
0.509
AC XY:
37825
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.412
AC:
17071
AN:
41470
American (AMR)
AF:
0.531
AC:
8111
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.484
AC:
1679
AN:
3470
East Asian (EAS)
AF:
0.570
AC:
2925
AN:
5128
South Asian (SAS)
AF:
0.481
AC:
2320
AN:
4820
European-Finnish (FIN)
AF:
0.567
AC:
5995
AN:
10566
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.553
AC:
37533
AN:
67928
Other (OTH)
AF:
0.483
AC:
1018
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1957
3914
5872
7829
9786
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
684
1368
2052
2736
3420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.536
Hom.:
96817
Bravo
AF:
0.501
Asia WGS
AF:
0.561
AC:
1950
AN:
3478
EpiCase
AF:
0.529
EpiControl
AF:
0.519

ClinVar

Significance: Benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 23, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2Other:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital stationary night blindness 1B Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
2.2
DANN
Benign
0.80
PhyloP100
-1.1
Mutation Taster
=71/29
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00019
dbscSNV1_RF
Benign
0.014
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2067011; hg19: chr5-178415937; COSMIC: COSV51447399; COSMIC: COSV51447399; API